Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Seasonal allergy

Recruiting

Registered drug

Short‑course sublingual ITULAZAX birch pollen extract with Lactobacillus rhamnosus GG for patients with pollen‑associated food allergy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Betula Verrucosa (108)

Contact Research Centre

Seasonal allergy+3

Recruiting

Investigational

Study on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma

Investigational

Spain

Participants:0–17 years · 18–64 years
Substances:Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified

Contact Research Centre

Seasonal allergy

Not yet recruiting

Registered drug

Study on the Effectiveness of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis and Possible Asthma

Registered drug

Poland

Participants:18–64 years
Substances:Placebo

Contact Research Centre

Seasonal allergy+3

Not yet recruiting

Registered drug

Efficacy and safety of 6‑grass pollen polymerized extracts 30,000 TU/mL and 10,000 TU/mL in adults with grass pollen‑induced allergic rhinitis/rhinoconjunctivitis, with or without mild‑to‑moderate asthma

Registered drug

Poland

Participants:0–17 years · 18–64 years
Substances:Bilastine

Contact Research Centre

Seasonal allergy

Not yet recruiting

Investigational

Dose-finding study of sublingual immunotherapy with phleum pratense extract (vs sodium chloride) in patients with grass pollen allergic rhinitis

Investigational

Spain

Participants:0–17 years · 18–64 years
Substances:Phleum Pratense

Contact Research Centre

Seasonal allergy

Not yet recruiting

Registered drug

Study to Find the Best Dose of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis, with or without Asthma

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Placebo

Contact Research Centre

Seasonal allergy+1

Not recruiting

Registered drug

Dose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis

Registered drug

Germany

Participants:18–64 years
Substances:Bilastine

Contact Research Centre

Seasonal allergy

Not recruiting

Registered drugNo placebo

Effect of a single oral dose of acalabrutinib on skin prick test wheal size in adults with grass pollen allergy using histamine dihydrochloride and phleum pratense

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Seasonal allergy+1

Not recruiting

Investigational

Study of sublingual immunotherapy with Phleum pratense pollen extract spray in patients with moderate to severe grass pollen allergic rhinitis

Investigational

Germany

Participants:18–64 years
Substances:Phleum Pratense Pollen Extract

Contact Research Centre

Seasonal allergy+1

Not recruiting

Investigational

Study of CLU-RX-PHL injection therapy for patients with moderate to severe grass pollen allergy to find the most effective and safe dose

Investigational

Germany

Participants:18–64 years
Substances:Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified

Contact Research Centre

Seasonal allergy+1

Not recruiting

Investigational

Study of sublingual birch pollen extract (SLI-RX-BET) in different doses for patients with moderate to severe allergic rhinitis caused by birch pollen

Investigational

Germany

Participants:18–64 years
Substances:Betula Pollen Extract

Contact Research Centre

Seasonal allergy+1

Not recruiting

Investigational

Study of CLU-RX-BET injection therapy for patients with moderate to severe birch pollen allergies

Investigational

Germany

Participants:18–64 years

Contact Research Centre

Find therapies in clinical trials near you

17 trials match your criteria

Seasonal allergy

Short‑course sublingual ITULAZAX birch pollen extract with Lactobacillus rhamnosus GG for patients with pollen‑associated food allergy

Seasonal allergy+3

Study on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma

Seasonal allergy

Study on the Effectiveness of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis and Possible Asthma

Seasonal allergy+3

Efficacy and safety of 6‑grass pollen polymerized extracts 30,000 TU/mL and 10,000 TU/mL in adults with grass pollen‑induced allergic rhinitis/rhinoconjunctivitis, with or without mild‑to‑moderate asthma

Seasonal allergy

Dose-finding study of sublingual immunotherapy with phleum pratense extract (vs sodium chloride) in patients with grass pollen allergic rhinitis

Seasonal allergy

Study to Find the Best Dose of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis, with or without Asthma

Seasonal allergy+1

Dose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis

Seasonal allergy

Effect of a single oral dose of acalabrutinib on skin prick test wheal size in adults with grass pollen allergy using histamine dihydrochloride and phleum pratense

Seasonal allergy+1

Study of sublingual immunotherapy with Phleum pratense pollen extract spray in patients with moderate to severe grass pollen allergic rhinitis

Seasonal allergy+1

Study of CLU-RX-PHL injection therapy for patients with moderate to severe grass pollen allergy to find the most effective and safe dose

Seasonal allergy+1

Study of sublingual birch pollen extract (SLI-RX-BET) in different doses for patients with moderate to severe allergic rhinitis caused by birch pollen

Seasonal allergy+1

Study of CLU-RX-BET injection therapy for patients with moderate to severe birch pollen allergies

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.